Delivery Order SPE2DX22D0030-SPE2D824F0LD2

Award Date 4/23/24
Potential Completion Date 4/24/24
Potential Value $167K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $579,265.94, was issued by the Medical Supply Chain division of the U.S. Department of Defense's Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 2025. Under this specific award, Amerisourcebergen will provide a variety of pharmaceutical...
This federal contract award, valued at $157,900.16, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. Under this specific award, Amerisourcebergen will provide a variety of pharmaceutical products and medical supplies,...
This federal contract award, valued at $35,638.65, was issued by the Medical Supply Chain division of the Department of Defense's Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $15,041.10, was issued by the Medical Supply Chain division of the U.S. Defense Department's Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $57,418.40, was issued by the Medical Supply Chain division of the U.S. Department of Defense's Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a wide range of pharmaceutical products and...
This federal contract award, valued at $768,340.87, was issued by the Medical Supply Chain division of the Defense Department's Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with a ceiling value of up to $999,999,999.00 that runs through December 2025. Under this IDC, Amerisourcebergen provides a wide range of pharmaceutical products and medical supplies to DLA...
This federal contract award, valued at $562,822.86, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Under this contract, Amerisourcebergen will provide a wide range of pharmaceutical products and medical...
This federal contract award, valued at $35,046.66, was issued by the Medical Supply Chain division of the U.S. Defense Department to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order placed under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999.00 through December 2025. The contract requires Amerisourcebergen to provide a range of pharmaceutical...
This federal contract award, valued at $71,470.15, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
This federal contract award, valued at $1,315.44, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Under this specific award, Amerisourcebergen will provide a range of pharmaceutical products and medical...
  • SPE2DX22D0030
    Indefinite Delivery Contract
  • SPE2DX22D0030-SPE2D824F0LD2
    Delivery Order

This federal contract award, valued at $166,891.44, was issued by the Medical Supply Chain division of the Department of Defense's Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025.

Under this contract, Amerisourcebergen will provide a range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and test kits, to support the DLA's mission to provide logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.

Generated 7/23/24, 11:14 AM